HLA-DR Allele frequencies in mexican mestizos with autoimmune liver diseases including overlap syndromes

Immunological Investigations

Volumn 38, Issue 3-4, 2009, Pages 276-283

  Zepeda Gomez, Sergio ^a   Montao Loza, Aldo ^a   Zapata Colindres, Juan Carlos ^a   Paz, Francisco ^a   Olivera Martinez, Marco ^a   Lpez Reyes, Alberto ^a   Granados, Julio ^a   Vargas Alarcn, Gilberto ^b  

^a INSTITUTO NACIONAL DE GERIATRÍA   (Mexico)

^b Instituto Nacional de Cardiologa Ignacio Chvez   (Mexico)

Author keywords

Autoimmune hepatitis; Overlap syndrome; Primary biliary cirrhosis

Indexed keywords

ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; BILIRUBIN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; IMMUNOGLOBULIN;

ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HEPATIC OVERLAP SYNDROME; HISTOPATHOLOGY; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SCORING SYSTEM;

ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN G; LIVER DISEASES; LIVER FUNCTION TESTS; MEXICO; SYNDROME;

EID: 70350635455     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130902846282     Document Type: Article

References (26)

1. Agarwal, K., Czaja, A. J., Jones De J., et al. (2000). CTLA-4 gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 31:49-53.
2. Alvarez, F., Berg, P. A., Bianchi, F. B., et al. (1999). International Autoimmune Hepatitis Group Report: review of criteria for Diagnosis of autoimmune hepatitis. J. Hepatol. 31:929-938.
3. Barquera, R., Vargas-Alarcon, G., Granados, J., et al. (2008). HLA class I and class II in admixed families from several regions on Mexico. Mol. Immunol. 45: 1171-1178.
4. Ben-Ari, Z., Czaja, A. J. (2001). Autoimmune hepatitis and its variants syndromes. Gut 49:589-594.
5. Beuers, U. (2005). Hepatic overlaps syndromes. J. Hepatol. 42:S93-S99.
6. Carpenter, H. A., Czaja, A. J. (2002). The role of histologic evaluation in the Diagnosis and management of autoimmune hepatitis and its variants. Clin. Liver Dis. 6:685-705.
7. Chazouilleres, O., Wendum, D., Sertafy, L., et al. (1998). Primary biliary cirrhosisautoimmune hepatitis overlap syndrome clinical features and response to therapy. Hepatology 28:296-301.
8. Cookson, S., Constantini, P. K., Clare, M., et al. (1999). Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 30:851-856.
9. Czaja, A. J. (1993). Chronic active hepatitis: The challenge for a new nomenclature. Ann. Intern. Med. 119:510-517.
10. Czaja, A. J. (1996). The variant forms of autoimmune hepatitis. Ann. Intern. Med. 125:588-598.
11. Czaja, A. J. (1998). Frequency and nature of the variant syndromes of autoimmune liver Disease. Hepatology 28:360-365.
12. Czaja, A. J. (2005). Current concepts in autoimmune hepatitis. Ann. Hepatol. 4:6-24.
13. Czaja, A. J., Carpenter, H. A. (2001). Autoimmune hepatitis with inciDental histologic features of bile duct injury. Hepatology 34:659-665.
14. Czaja, A. J., Cookson, S., Constantini, P. K., et al. (1999). Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology 117:645-652.
15. Czaja, A. J., Sievers, C., Zein, N. N. (2000). Nature and behavior of serum cytokines in type 1 autoimmune hepatitis. Dig. Dis. Sci. 45:1028-1035.
16. Czaja, A. J., Manns, M. P., McFarlane, I. G., et al. (2000). Autoimmune hepatitis: The investigational and clinical challenges. Hepatology 31:1194-1200.
17. Czaja, A. J., Santrach, P., Moore, B., et al. (2001). Shared genetics risk factors in autoimmune liver Disease. Dig. Dis. Sci. 46:140-147.
18. Donaldson, P., Doherty, D., UnDerhill, J., et al. (1994). The molecular genetics of autoimmune liver Disease. Hepatology 1994; 20:225-239.
19. Goodman, Z. D., McNally, P. R., Davis, D. R., Ishak, K. G. (1995). Autoimmune cholangitis: a variant of primary biliary cirrhosis. Dig. Dis. Sci. 40:1232-1242.
20. Gores, J. G., Moores, S. B., Fisher, L. D., et al. (1987). Primary biliary cirrhosis: associations with class II major histocompability complex antigens. Hepatology 7:889-892.
21. Lohse, A. W., zum BuschenfelDe, K.-H. M., Franz, B., et al. (1999). Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: eviDence for its being a hepatic form of PBC in genetically susceptible inDividuals. Hepatology 29:1078-1084.
22. Manns, M. P., Bremm, A., SchneiDer, P. M., et al. (1991). C4 Deficiency as risk factors in primary biliary cirrhosis, Gastroenterology 101:1367-1373.
23. Mieli-Vergani, G., Lobo-Yeo, A., McFarlane, B. M., et al. (1989). Different immune mechanisms leaDing to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology 9:198-203. (Pubitemid 19063301)
24. Mullarkey, M. E., Stevens, A. M., McDonnel, W. M., et al. (2005). Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis. Tissue Antigens 65:199-205.
25. Vazquez-Garcia, M. N., Alaez, C., Olivo, A., et al. (1998). MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J. Hepatol. 28:985-990.
26. Woodward, J., Neuberger, J. (2001). Autoimmune overlaps syndromes. Hepatology 33: 994-1002.